YTHDF2 and glioblastoma: In addition, the m6A methylation-binding protein YTHDF2 was found to affect tumor growth in mice through the YTHDF2-MYC-IGFBP3 pathway, providing a new target for the treatment of GBM (Dixit et al., 2021).